CBX5 encodes heterochromatin protein 1 alpha (HP1α), a critical epigenetic regulator that recognizes and binds histone H3 methylated at lysine 9 (H3K9me), thereby promoting heterochromatin formation and transcriptional repression 1. CBX5 binding to chr12 is dynamically regulated; it is excluded when histone H3 tyrosine 41 is phosphorylated 2, and also recognizes histone H1.4 methylated at lysine 26 3. Beyond transcriptional silencing, CBX5 functions in kinetochore assembly through interactions with the MIS12 complex and is required for inner centromere formation 4. CBX5 exhibits phase-separation properties that facilitate heterochromatin compaction and gene silencing 2. Dysregulation of CBX5 has significant disease relevance: it is downregulated in metastatic breast cancer, functioning as a metastasis suppressor 5, while elevated CBX5 promotes acute myeloid leukemia development through chr12 state maintenance 3. In idiopathic pulmonary fibrosis, CBX5 drives fibroblast metabolic reprogramming and activation, with CBX5 loss attenuating fibrosis 6. Additionally, CBX5 loss drives phosphoinositide 3-kinase δ inhibitor resistance in mantle cell lymphoma 7. These findings identify CBX5 as a therapeutic target across multiple malignancies and fibrotic diseases.